Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
基本信息
- 批准号:10589388
- 负责人:
- 金额:$ 4.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdoptionBehaviorBehavioralBlack PopulationsClinicalClinical TrialsCommunitiesCoupledDataDecision MakingDrug userEducationEducational process of instructingElectronic Health RecordElementsEnvironmentEvidence based practiceFentanylFundingGoalsHarm ReductionHealthHealth PersonnelHealth ProfessionalHealth systemHealthcare SystemsHeterogeneityHomeHospital DepartmentsHospitalsHybridsIncidenceIndividualInjectionsInterventionInterviewKnowledgeLeadMapsMeasuresMedicalMethodologyModelingMorbidity - disease rateMotivationNaloxoneOpioidOutcomeOverdoseOverdose reductionPatient RecruitmentsPatient Self-ReportPatientsPersonsPopulationProcessPublic HealthRaceRandomized Controlled TrialsResearchRiskSamplingSelf EfficacySeriesServicesSiteSkin TissueSoft Tissue InfectionsStructureSubstance Use DisorderSurveysTeaching MethodTestingText MessagingTheoretical Domains frameworkTrustUnited States National Institutes of Healthacute carebasebehavior changebehavioral health interventionclinical carecommunity settingdesignefficacy evaluationevidence baseexperiencehealth care settingshealth equityhuman centered designimplementation barriersimplementation facilitatorsimplementation frameworkimprovedimproved outcomeinternalized stigmamortalitynovelopioid use disorderoverdose deathpatient-level barrierspeerprimary outcomeprovider-level barriersracial disparityreduced substance useservice gapskillssocial stigmasubstance usesystem-level barrierstest striptherapy designtreatment as usualtreatment effect
项目摘要
ABSTRACT
People who use drugs (PWUD) with acute medical problems have high rates of subsequent mortality and
morbidity related to substance use, with notable racial disparities. While harm reduction services to reduce
overdose and injection-related complications have historically functioned outside of health care settings,
integrating harm reduction into acute care clinical settings could improve these outcomes. There is a critical
gap in how best to implement harm reduction services in the health system that will lead to effective behavioral
change and address equity gaps. Our study proposes to develop an acceptable, feasible, and effective peer-led
bundle of harm reduction services. Our overall objectives are to tailor the THRIVE (Teaching Harm Reduction
In Vulnerable Environments) intervention and determine its efficacy in changing behaviors and reducing
health risks among PWUD. The THRIVE intervention was conceptualized by our team along with people with
lived experience and informed by the COM-B model for Behavior Change and the Theoretical Domains
Framework. THRIVE bundles evidence-based harm reduction strategies (e.g. safer injection education, take
home naloxone, and fentanyl test strips). It includes a face-to-face session boosted by weekly text messages and
electronic content. Content is delivered over 12 weeks. Our research team has the extensive expertise in
community-partnered research, qualitative methodology, behavioral health intervention design, and clinical
trial management needed to successfully complete the proposed aims. We will use a human-centered design
approach to tailor the THRIVE model and address the patient, provider, and systems-level barriers to
implementation in hospital and emergency-department settings. This includes a “Design Sprint” in which
PWUD will map the problem (guided by qualitative interviews with patients and healthcare providers), sketch
implementation elements, choose the key aspects to develop, and build model components. These
implementation methods for the THRIVE model will then be user-tested with 20 patients over an 8-week
period. We will then examine the efficacy of the THRIVE intervention in reducing the cumulative incidence of
self-reported non-fatal overdose or skin and soft tissue infection between baseline and 6-months among
PWUD in a hybrid type 1 randomized controlled trial. We will conduct a randomized controlled trial recruiting
patients (n=390) admitted to the hospital or Emergency Department with opioid use disorder in one of three
hospitals. We will also analyze implementation barriers and facilitators of the THRIVE model using the health
equity implementation framework to identify any needed implementation supports for widescale
implementation.
摘要
有急性医疗问题的药物使用者(PWUD)随后的死亡率很高,
与药物使用有关的发病率,有明显的种族差异。虽然减少危害服务可以减少
用药过量和注射相关并发症历来在医疗保健机构之外发生,
将减少伤害纳入急性护理临床环境可以改善这些结果。存在一个临界
如何在卫生系统中最好地实施减少伤害服务,从而导致有效的行为
改变和解决公平差距。我们的研究建议发展一个可接受的,可行的,有效的同行领导的
减少伤害的服务。我们的总体目标是量身定制THRIVE(教学减少伤害
在脆弱环境中)干预,并确定其在改变行为和减少
PWUD的健康风险。THRIVE干预是由我们的团队沿着与患有以下疾病的人一起概念化的
生活经验,并告知COM-B模型的行为改变和理论领域
框架. THRIVE捆绑了基于证据的减少危害策略(例如,更安全的注射教育,采取
家用纳洛酮和芬太尼测试条)。它包括每周一次的短信推动的面对面会议,
电子内容。内容在12周内交付。我们的研究团队拥有广泛的专业知识,
社区合作研究、定性方法、行为健康干预设计和临床
为成功实现拟议目标,需要进行审判管理。我们将采用以人为本的设计
一种方法来定制THRIVE模型,并解决患者、提供者和系统级障碍,
在医院和急诊室环境中实施。这包括一个“设计冲刺”,
PWUD将绘制问题(通过与患者和医疗保健提供者的定性访谈进行指导),
实现元素,选择要开发的关键方面,并构建模型组件。这些
THRIVE模型的实施方法将在8周内对20名患者进行用户测试
期然后,我们将研究THRIVE干预在降低累积发病率方面的有效性。
基线至6个月期间自我报告的非致死性药物过量或皮肤和软组织感染,
混合1型随机对照试验中的PWUD。我们将进行随机对照试验,
三分之一的阿片类药物使用障碍住院或急诊的患者(n=390)
医院的我们还将分析实施的障碍和促进因素的繁荣模式使用的健康
公平执行框架,以确定为实现公平所需的任何执行支助
实施.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline Deanna Wilson其他文献
Jacqueline Deanna Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline Deanna Wilson', 18)}}的其他基金
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10834850 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
- 批准号:
10834851 - 财政年份:2022
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10053965 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10424528 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10197083 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Standard Grant














{{item.name}}会员




